Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
about
Treatment for constipation: new and old pharmacological strategiesCalculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology AppointmentIrritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating.Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies.Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.The microbiota-gut-brain axis in functional gastrointestinal disorders.The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trialsDetermination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects.Resting anal pressure, not outlet obstruction or transit, predicts healthcare utilization in chronic constipation: a retrospective cohort analysis.Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.Effective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis.Balance of Autonomic Nervous System Predicts Who Benefits from a Self-management Intervention Program for Irritable Bowel SyndromeLactulose Hydrogen Breath Test Result Is Associated with Age and GenderThe gut microbiota and psychiatric illness.The role of bile acids in functional GI disorders.Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency.Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.Smoking in Irritable Bowel Syndrome: A Systematic Review.Multiple functional gastrointestinal disorders linked to gastroesophageal reflux and somatization: A population-based study.Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis.Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care.Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia.Rectal Gas Volume Measured by Computerized Tomography Identifies Evacuation Disorders in Patients With Constipation.Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice.Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care.Proteomics and irritable bowel syndrome.Self-Perceived Food Intolerances Are Common and Associated with Clinical Severity in Childhood Irritable Bowel Syndrome.Risk Factors for the Presence of Symptoms in Peptic Ulcer Disease.Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population.No increase in prevalence of somatization in functional vs organic dyspepsia: a cross-sectional survey.Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey.Study design considerations for irritable bowel syndrome clinical trials.Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study.Frequency patterns of core constipation symptoms among the Asian adults: a systematic review.Establishing a nurse-led pelvic floor and functional bowel service.The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.Alterations in serotonin metabolism in the irritable bowel syndrome.Editorial: subgroups in irritable bowel syndrome-more than just diarrhoea and constipation?A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea.Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same?
P2860
Q27027346-1E1BC83F-9E66-466D-979B-97C071AC1D45Q28603996-7C9B2B05-DDA4-4F30-8807-1436F528F93AQ33463901-29184295-6ACC-4D3C-B4D8-9E3D15EA4F24Q33628494-C0CB83E8-FF85-4B86-839D-1265410D3B03Q33661343-7081AC12-8975-4FC2-AF87-B2221A9C4A39Q34129427-57FF2647-7D16-414A-9FDB-1381E984E3D1Q34782198-EB4B2081-DE6D-48C5-AFF7-C6354CEE1DB9Q35649153-204FE440-02F9-427E-BF6A-DBF4725FC383Q36096138-609A95B9-4218-4845-AF0F-77CFCBBD0019Q36310200-8C698A8C-D5B1-47E0-97AB-F21C3CCB999BQ36426025-BA6DF1FD-0319-409A-B4B2-AFC9A76A0981Q36426060-792CE1C9-B337-4C36-A45B-D6F5FD209411Q36747480-40A58955-F1EE-4460-954D-8A34DC935EBFQ37730411-10E84FB2-6504-47E8-A257-152DEB325845Q38217671-674957CD-6107-4AF0-9242-0BECD5B6D191Q38474305-FCFA0644-74CA-4129-8A34-8F53312FA59EQ38582664-D8A8A282-9AE2-4A43-BFE9-EE0295D3717BQ38727941-253DBA17-D973-43A8-A147-B8EC444D28F1Q38931615-BE9D4246-6F94-413C-9FA9-2EEB24F77F5BQ39010841-1C7E683F-4742-4A0C-BFED-A08C876673BCQ39013737-3FB0ECE3-9B8A-4F81-AD14-C496486663B0Q39101083-1A5412AD-B887-4947-ACB3-E24D2C600728Q39179796-21F6B204-574B-44D5-A413-C62A1C8E492AQ39218204-8A7433B2-1002-4098-8EDD-4C9E153ED8F4Q39221766-8D7B6C23-4F71-416F-8F91-AA6B3B58CFB2Q39232397-4ADB24CB-865A-4F9C-93E2-82FBAD365AB8Q39674356-9C773729-E5F2-4BA4-9904-1A88434E9CF4Q40398168-93573AD9-754B-4137-8226-4AD33946C6E6Q40718940-6E5FE1CB-96A8-438F-8EA2-8C93FD9B7D61Q40990248-D2877526-F37C-4936-85CE-BA6F437B285BQ41504455-F09E38BD-3812-43E1-A990-236DEB343ECCQ42934168-B608ABFE-2F2F-43D4-A867-C622447B0FE5Q43319840-3C082BA2-F29B-4346-B07D-7446EFA95F0DQ43366179-ED05D791-1386-4216-A3E3-1D4CF3379281Q47351542-2C896E45-8D2B-457E-B54D-9B4F69C7D2C7Q47574638-96DEECCE-C54D-45D5-86EE-50B66E96403FQ47920570-70912722-104D-4568-AC5F-0490B87A0AF3Q48112798-E3E413DF-74CE-493B-9846-C2B3A87111ACQ50079125-CBDE4654-D9AB-40D5-81AB-F4CFAE2FB118Q52815301-3AC6FF76-05C5-4FEA-A23B-4601B6D520CF
P2860
Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Characteristics of functional ...... y using the Rome III criteria.
@en
Characteristics of functional ...... y using the Rome III criteria.
@en-gb
Characteristics of functional ...... y using the Rome III criteria.
@nl
type
label
Characteristics of functional ...... y using the Rome III criteria.
@en
Characteristics of functional ...... y using the Rome III criteria.
@en-gb
Characteristics of functional ...... y using the Rome III criteria.
@nl
prefLabel
Characteristics of functional ...... y using the Rome III criteria.
@en
Characteristics of functional ...... y using the Rome III criteria.
@en-gb
Characteristics of functional ...... y using the Rome III criteria.
@nl
P2093
P2860
P356
P1476
Characteristics of functional ...... y using the Rome III criteria.
@en
P2093
D G Morgan
M I Pintos-Sanchez
P2860
P304
P356
10.1111/APT.12573
P407
P577
2013-12-05T00:00:00Z